Aeglea BioTherapeutics Inc

NASDAQ:AGLE   3:58:40 PM EDT
0.50
+0.04 (+8.80%)
Earnings Announcements

Aeglea Biotherapeutics Reports Second Quarter 2022 Financial Results

Published: 08/04/2022 10:21 GMT
Aeglea BioTherapeutics Inc (AGLE) - Aeglea Biotherapeutics Reports Second Quarter 2022 Financial Results and Provides Program Updates.
Aeglea Bio Therapeutics - Qtrly Loss per Share $0.27.
Revenue is expected to be $0.16 Million
Adjusted EPS is expected to be -$0.27

Next Quarter Revenue Guidance is expected to be $0.16 Million
Next Quarter EPS Guidance is expected to be -$0.28

More details on our Analysts Page.